About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Transition of Chairman of Board

April 21, 2017

Click here to read more

Post navigation

Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast

Phosphagenics Notice of Annual General Meeting

Related Posts

Phosphagenics Still Awaits SIAC Arbitration Update

June 8, 2018

Avecho receives US$3M upfront payment from Sandoz AG

March 28, 2025March 28, 2025

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Recent Posts

Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.